Le Lézard
Classified in: Health
Subjects: VET, CSR

DaVita Recognized for Veteran Outreach


DENVER, July 16, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, today announced it has been recognized by the Disabled American Veterans (DAV) as the 2018 Outstanding Large Employer of the Year.

DaVita Recognized for Veteran Outreach

Since 2010, DaVita has hired over 3,000 veteran teammates, offering transitional support for teammates with a military background. Veteran teammates vary from patient care technicians to the organization's current chief development officer. DaVita has long been committed to honoring retired and active-duty service members and works to help them feel welcome in the community and to transition from life in the military to life as teammates at DaVita.

"We believe in going the extra mile to hire and develop veterans because they went to many extra miles for our country," said Kent Thiry, chairman and CEO of DaVita Inc.

DaVita's Veterans 2 Village (V2V) program is a two-day class introduced in 2016 that focuses on self-development and introduces new veteran teammates to all of DaVita's existing military programs and benefits. DaVita's internal veterans' programs are designed to foster a stronger community for new veteran teammates, as the company's support services continue to develop and grow.

Each year, DaVita hosts Veterans Day celebrations at many of its clinics and business offices. Some celebrations include putting together care packages for troops overseas and writing notes of encouragement for service men and women. In addition, workshops and development courses are offered to help foster a stronger community for new veteran teammates.

Recipients of this award are evaluated on several criteria including the strength of the company's veteran recruiting/hiring efforts, retention and career-building efforts, company policies toward disabled veterans, active-duty, and veteran employees and community outreach initiatives to support all veterans in communities where the business operates.

Explore how DaVita cares for its teammates, its patients and the world at DaVita.com/CSR.

About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of March 31, 2018, DaVita Kidney Care operated or provided administrative services at 2,539 outpatient dialysis centers located in the United States serving approximately 198,000 patients. The company also operated 241 outpatient dialysis centers located in 10 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/About.

Contact Information

Caitlyn Major
[email protected]  
303.876.7547

 

DaVita logo. (PRNewsFoto/DaVita)

SOURCE DaVita Inc.


These press releases may also interest you

at 07:13
Throughout July, Kevin Guest, executive chairman at USANA Health Sciences , is emphasizing boosting social connections during "Social Wellness Month." Social wellness?the ability to form meaningful relationships and interact positively with...

at 07:10
The Board of Certification for Emergency Nursing (BCEN), the benchmark for nursing specialty certification across the emergency spectrum, named Maris Panjada as BCEN's new marketing and communications director following the June 28 retirement of...

at 07:05
Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®Liquid CDx to be used as a companion diagnostic for AKEEGA® (niraparib and abiraterone acetate) from Janssen...

at 07:05
Novocure announced today that it will report financial results for the second quarter 2024 on Thursday, July 25, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company's...

at 07:05
AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open and recruiting patients...

at 07:05
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...



News published on and distributed by: